Verdict Medical Devices

Medtronic announces two-year trial outcomes of Evolut TAVR

Medtronic has announced the SMART trial’s two-year outcomes of Evolut TAVR for aortic stenosis (AS) and small aortic annulus. The post Medtronic announces two-year trial outcomes of Evolut TAVR appeared first on Medical Device Network.

Mar 10, 2025 - 12:42
 0
Medtronic announces two-year trial outcomes of Evolut TAVR
Medtronic has announced the SMART trial’s two-year outcomes of Evolut TAVR for aortic stenosis (AS) and small aortic annulus.

The post Medtronic announces two-year trial outcomes of Evolut TAVR appeared first on Medical Device Network.

Read More

Tags:

Previous Article

FDA grants 510(k) clearance to Zimmer’s new revision knee implant component

Next Article

Globe Metals signs offtake agreement with Myst Trading for Malawi’s Kanyika Project

Related Posts

Boston Scientific buys Tivus system developer SoniVie in $540m deal

Boston Scientific buys Tivus system developer SoniVie i...

Mar 4, 2025  0

Level Zero Health raises $6.9m for hormone tracking biosensor platform

Level Zero Health raises $6.9m for hormone tracking bio...

Feb 19, 2025  0

FDA tags Sentec/Percussionaire’s breathing circuit recall as Class I

FDA tags Sentec/Percussionaire’s breathing circuit reca...

Feb 11, 2025  0